Tubidy
    Part 3 - Interpretating NGS, MSI-MMR, TMB: from Lab to Clinic - Dr B K Smruti, Mumbai

    Part 3 - Interpretating NGS, MSI-MMR, TMB: from Lab to Clinic - Dr B K Smruti, Mumbai

    19:43 |
    Download MP3

    Related Videos

    Hall D - Day 2, Fortis Cancer Summit 2024 9:49:59

    Hall D - Day 2, Fortis Cancer Summit 2024

    Part 2- Sexual Activity and Vaginal Functioning in Patients with Advanced Cervical Cancer- Dr Shipra 5:47

    Part 2- Sexual Activity and Vaginal Functioning in Patients with Advanced Cervical Cancer- Dr Shipra

    Part 1 - Introduction and welcome - Dr Ashok K Vaid and Dr Nitin Sood 2:23

    Part 1 - Introduction and welcome - Dr Ashok K Vaid and Dr Nitin Sood

    Part 11- Management of Relapsed Refractory Multiple Myeloma:Noval Treatment Options- Dr Uday 18:19

    Part 11- Management of Relapsed Refractory Multiple Myeloma:Noval Treatment Options- Dr Uday

    Hall C - Day 2, Fortis Cancer Summit 2024 5:56:06

    Hall C - Day 2, Fortis Cancer Summit 2024

    LIVER CANCER MASTERCLASS 2:57:54

    LIVER CANCER MASTERCLASS

    Shifting treatment paradigm in management of Chronic Lymphocytic Leukemia 2:51:48

    Shifting treatment paradigm in management of Chronic Lymphocytic Leukemia

    Part 11 - Evolution of Antibody Drug conjugates in cancer - Dr. Gail Phillips, USA 28:55

    Part 11 - Evolution of Antibody Drug conjugates in cancer - Dr. Gail Phillips, USA

    Webinar on the occasion of THE WORLD LYMPHOMA DAY 2:52:44

    Webinar on the occasion of THE WORLD LYMPHOMA DAY

    World Kidney Cancer Day 5:20

    World Kidney Cancer Day

    Part 14 - Panel Discussion: Optimal Management of High Grade B Cell Lymphomas - Dr Deepesh Lad 27:48

    Part 14 - Panel Discussion: Optimal Management of High Grade B Cell Lymphomas - Dr Deepesh Lad

    Hall A - Day 1, Fortis Cancer Summit 2024 8:09:02

    Hall A - Day 1, Fortis Cancer Summit 2024

    Part 5 - Optimal Management of Mutation Negative Advanced Lung Cancer - Dr Anubha Bhartuar 24:30

    Part 5 - Optimal Management of Mutation Negative Advanced Lung Cancer - Dr Anubha Bhartuar

    Part 2 - Quality Assurance of Contouring for NRG Oncology/RTOG 1308 Clinical Trial - Dr Sarthak 7:08

    Part 2 - Quality Assurance of Contouring for NRG Oncology/RTOG 1308 Clinical Trial - Dr Sarthak

    Part 2 - Randomized Clinical Trial on 7-days-a-week Postoperative Radiotherapy - Dr Bhanu 3:34

    Part 2 - Randomized Clinical Trial on 7-days-a-week Postoperative Radiotherapy - Dr Bhanu

    01 Fragile Let's talk about 2:19

    01 Fragile Let's talk about

    Changing Sickle Cell Scenario in India 6:42:57

    Changing Sickle Cell Scenario in India

    Part 5 - Case Based Discussion on optimal management of metastatic RCC & bladder Cancer - Dr T. Raja 30:21

    Part 5 - Case Based Discussion on optimal management of metastatic RCC & bladder Cancer - Dr T. Raja

    14th Ugam Anniversary celebration, 2023 2:53:46

    14th Ugam Anniversary celebration, 2023

    National Quiz on Bone & Soft Tissue Tumours 3:28:47

    National Quiz on Bone & Soft Tissue Tumours